| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/13/1997 | US5628996 Method for inhibiting the viability of Pseudomonas aeruginosa with cross-reactive and cross-protective monoclonal antibodies |
| 05/09/1997 | WO1997016728A1 FORMATION AND USE OF PRION PROTEIN (PrP) COMPLEXES |
| 05/09/1997 | WO1997016727A1 Assay background reduction using glycoproteins with oxidized carbohydrates |
| 05/09/1997 | WO1997016557A1 TREATMENT OF TUMOURS BY ADOPTIVE TRANSFER OF CD44v-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
| 05/09/1997 | WO1997016552A1 Dna sequences encoding cmh-1, a cysteine protease involved in apoptosis |
| 05/09/1997 | WO1997016549A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | WO1997016548A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS |
| 05/09/1997 | WO1997016542A1 Diagnostics and treatments of periodontal disease |
| 05/09/1997 | WO1997016540A1 Chitin synthase 1 |
| 05/09/1997 | WO1997016461A1 Monoclonal antibody specific for prostaglandin d synthetase |
| 05/09/1997 | WO1997016457A2 Anti-tumoral protein |
| 05/09/1997 | WO1997016221A2 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | WO1997016209A1 Expression of cyclin g1 in tumors |
| 05/09/1997 | WO1997016206A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/09/1997 | WO1997016201A1 Angiotensin iv and analogs as regulators of fibrinolysis |
| 05/09/1997 | CA2236419A1 Neurogenic differentiation (neurod) genes and proteins |
| 05/09/1997 | CA2236297A1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | CA2235623A1 Dna sequences encoding cmh-1, a cysteine protease involved in apoptosis |
| 05/09/1997 | CA2234102A1 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | CA2233881A1 Chitin synthase 1 |
| 05/09/1997 | CA2209314A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/07/1997 | EP0771819A1 Monoclonal antibody specific to nitrifying bacteria and method for detection thereof |
| 05/07/1997 | EP0771356A1 Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitope |
| 05/07/1997 | EP0771351A1 Surface protein of staphylococcus aureus |
| 05/07/1997 | EP0771327A1 Contraceptive vaccine |
| 05/07/1997 | EP0771326A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same |
| 05/07/1997 | EP0771325A1 Process for modifying the stability of antibodies |
| 05/07/1997 | EP0771216A1 Methods and compositions for the specific coagulation of vasculature |
| 05/07/1997 | EP0771215A1 Retroviral transduction of cells using soluble complement inhibitors |
| 05/07/1997 | EP0771213A1 Haemophilus adherence and penetration proteins |
| 05/07/1997 | EP0771208A1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 05/07/1997 | EP0771192A1 Use of anti-vegf agents in the treatment of endometriosis |
| 05/07/1997 | EP0661993B1 Protection against liver damage by hgf |
| 05/07/1997 | EP0570583B1 Hair modifier and hair care product, both containing antikeratinous antibody, and production of antikeratinous antibody |
| 05/07/1997 | EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene |
| 05/07/1997 | DE19540902A1 Protein mit Anti-Tumorwirkung Protein with anti-tumor activity |
| 05/07/1997 | CN1149299A Anti-GP39 antibodies and uses therefor |
| 05/07/1997 | CN1149257A Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/06/1997 | USRE35500 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 05/06/1997 | US5627267 Cytokine designated elk ligand |
| 05/06/1997 | US5627262 Method and composition for the treatment of septic shock |
| 05/06/1997 | US5627073 Hybridomas producing antibodies to cardiac hypertrophy factor |
| 05/06/1997 | US5627067 Monoclonal antibodies cross-reactive and cross-protective against human monoclonal antibodies against pseudomonas aeruginosa serotypes |
| 05/06/1997 | US5627064 Protein kinases |
| 05/06/1997 | US5627052 Methods for the production of proteins with a desired function |
| 05/06/1997 | US5626846 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 05/06/1997 | US5626845 Method to ameliorate osteolysis and metastasis |
| 05/06/1997 | US5626844 Monoclonal antibody against ricin A chain |
| 05/06/1997 | US5626843 Treatment of autoimmune diseases, including AIDS, by removel of interferons, TNFs and receptors therefor |
| 05/06/1997 | US5626830 Producing image of damage |
| 05/02/1997 | EP0770874A2 Receptor membranes and ionophore gating |
| 05/02/1997 | EP0770680A2 Lymphocyte-associated cell surface protein |
| 05/02/1997 | EP0770679A2 HCV-specific peptides, preparations related to them and their use |
| 05/02/1997 | EP0770628A1 Reconstituted human antibody against human interleukin-8 |
| 05/02/1997 | EP0770627A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 05/02/1997 | EP0770398A2 Pharmaceutical composition comprising a lens antigen for treatment of cataract |
| 05/02/1997 | EP0770396A2 Use of new factor VIII coagulant polypeptides |
| 05/02/1997 | EP0770141A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-1 AND 2 |
| 05/02/1997 | EP0770138A2 Mycobacteria functional screening and/or expression vectors |
| 05/02/1997 | EP0770136A1 Method for selecting high-expressing host cells |
| 05/02/1997 | EP0770135A1 Novel compounds |
| 05/02/1997 | EP0770092A1 $i(HELICOBACTER PYLORI) NICKEL BINDING PROTEIN |
| 05/02/1997 | EP0770089A1 Growth differentiation factor-12 |
| 05/02/1997 | EP0770088A1 Novel cytokine designated lerk-5 |
| 05/02/1997 | EP0770087A1 Human elastase iv |
| 05/02/1997 | EP0770086A1 Macrophage migration inhibitory factor-3 |
| 05/02/1997 | EP0769964A2 Cck antibodies used to improve feed efficiency |
| 05/02/1997 | EP0769958A1 Inhibitors of leukocyte adhesion |
| 05/02/1997 | EP0769955A1 Non-antigenic amine derived polymers and polymer conjugates |
| 05/02/1997 | EP0698212A4 Methods of using antibodies against human luteinizing hormone-related determinants |
| 05/02/1997 | EP0651803B1 Protein expression system |
| 05/01/1997 | WO1997015830A1 A method for detecting a mammal's prior exposure to radiation or radiomimetic chemicals |
| 05/01/1997 | WO1997015675A1 An isolated and purified dna molecule and protein for the degradation of triazine compounds |
| 05/01/1997 | WO1997015674A1 Progestin-regulated gene |
| 05/01/1997 | WO1997015671A1 Luminal cholecystokinin-releasing factor |
| 05/01/1997 | WO1997015669A1 Chimeric receptor genes and cells transformed therewith |
| 05/01/1997 | WO1997015667A1 Biologically active eph family ligands |
| 05/01/1997 | WO1997015666A1 Therapeutic antiangiogenic compositions and methods |
| 05/01/1997 | WO1997015663A1 A novel haemopoietin receptor and genetic sequences encoding same |
| 05/01/1997 | WO1997015601A1 Process for the preparation of a single chain fv antibody fragment |
| 05/01/1997 | WO1997015599A1 Novel acetaldehyde and malondialdehyde protein adducts as markers for alcohol liver disease |
| 05/01/1997 | WO1997015592A1 Novel human cysteine protease |
| 05/01/1997 | WO1997015327A1 Methods of treating established colitis using antibodies against il-12 |
| 05/01/1997 | WO1997015326A1 Remedy for hepatitides |
| 05/01/1997 | WO1997015325A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 05/01/1997 | WO1997015324A1 High fluorescence specific immune enhancing factor and methods of use for same |
| 05/01/1997 | WO1997015243A1 Induction of immunological tolerance |
| 05/01/1997 | CA2238940A1 Luminal cholecystokinin-releasing factor |
| 05/01/1997 | CA2235599A1 High fluorescence specific immune enhancing factor and methods of use for same |
| 05/01/1997 | CA2235575A1 Novel human cysteine protease |
| 05/01/1997 | CA2234647A1 Use of linalool synthase in genetic engineering of scent production |
| 05/01/1997 | CA2233882A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 04/30/1997 | CN1148505A Activated immune globulin |
| 04/29/1997 | US5625126 Transgenic non-human animals for producing heterologous antibodies |
| 04/29/1997 | US5625039 Anti-human IgE monoclonal antibodies |
| 04/29/1997 | US5625038 Monoclonal antibodies specific for Erysipelothrix rhusiopathiae |
| 04/29/1997 | US5625037 Antibodies, method of preparing same, oligosaccharides and clones for providing said antibodies, and the use of said antibodies for tumor diagnosis and therapy |
| 04/29/1997 | US5625034 Core antigen protein of hepatitis C virus, and diagnostic method and kit using the same |
| 04/29/1997 | US5625033 Heterofunctinal binding fusion proteins |
| 04/29/1997 | US5624899 Ligands and proteins |